Document is current
Any future updates will be listed below
-
Authors
Sánchez, Jorge https://orcid.org/0000-0001-6341-783X
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 29 January 2026
First Online: 12 March 2026
Declarations
:
: Professor Sánchez has been an advisor and speaker for Novartis AG; Sanofi SA; Glaxon; AstraZeneca PLC; Becton Dickinson and Company; Foundation for Advanced Education in the Sciences, Inc; Galderma SA; Nettle Pharma; and Thermo Fisher Scientific Inc.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author.
